Myeloid Leukemia — Trials

Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,531 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 859
Recruiting: 496
Ph III recruiting: 47
Growth YoY: +2.9%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (621)

clinicaltrialsPublishedShowing 401–450 of 1,516 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05358808	ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML)(ACHIEVE)	terminated	Phase 2	16	TC BiopharmINDUSTRY	1	Sep 30, 2025	clinicaltrials
NCT02917720	2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients(NAUT)	active not recruiting	Phase 2	75	European LeukemiaNetNETWORK